Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

On November 15, 2023, The US FDA Informed Orchard Therapeutics It Will Not Schedule An Advisory Committee Meeting For The Review Of The Co's Biologics License Application For The Commercialization Of OTL-200 In The US To Treat Metachromatic Leukodystrophy

Author: Benzinga Newsdesk | November 21, 2023 09:13am

- SEC Filing

Posted In: ORTX